CBLL - NASDAQ

CeriBell, Inc.

CBLL·NASDAQ

$18.63

+6.5%

HealthcareMedical - Devices

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$706.87M

EPS-1.4600

P/E Ratio-12.76

Earnings Date08/04/2026

cbll

Net Cash Provided by Financing Activities

Last Annual Value

5.05M

3-Year CAGR

-53%

5-Year CAGR

-37%

10-Year CAGR

-20%

Adjust for Inflation

CeriBell, Inc. Competitors Analysis of Net Cash Provided by Financing Activities

CBLL · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
CeriBell, Inc. NASDAQ:CBLL	5.05M	N/A	N/A	N/A
Treace Medical Concepts, Inc. NASDAQ:TMCI	2.08M	-73.3%	-54.6%	N/A
Standard BioTools Inc. NASDAQ:LAB	570.00K	N/A	-48.6%	22.3%
Butterfly Network, Inc. NYSE:BFLY	77.76M	598.7%	-32.8%	N/A
Enhabit, Inc. NYSE:EHAB	-72.20M	N/A	N/A	N/A
OrthoPediatrics Corp. NASDAQ:KIDS	23.98M	48.6%	425.2%	20.9%
Quantum-Si incorporated NASDAQ:QSI	95.42M	762.0%	-28.7%	N/A
Semler Scientific, Inc. NASDAQ:SMLR	117.19M	N/A	518.0%	45.1%
Varex Imaging Corporation NASDAQ:VREX	-75.90M	N/A	N/A	N/A
Surmodics, Inc. NASDAQ:SRDX	-2.95M	N/A	N/A	N/A

CeriBell, Inc. Fair Value Envelope

CBLL · NASDAQ

Our analysis suggests that CBLL has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $18.63, this represents a potential HIDDEN relative to our calculated worth for CeriBell, Inc..

HIDDEN

Intrinsic Value

Current Price: $18.63

Related Guides

Blog Categories

Continue your CBLL research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.